Odyssean »

Nuvation Bio shares owned by Odyssean

Quarter-by-quarter ownership of Nuvation Bio (NUVB) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Nuvation Bio

Tip: Access up to 7 years of quarterly data

All positions including Nuvation Bio held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvation Bio by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $954k 168k 5.68

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Nuvation Bio

FMR
Decheng Capital
BlackRock
Vanguard Capital Management
Omega Fund Management
Laurion Capital Management
State Street Corporation
Geode Capital Management
Duquesne Family Office
American Century Companies
Tang Capital Management
Bank of America Corporation
Redmile Group
Vanguard Portfolio Management
Two Sigma Investments

View all funds holding Nuvation Bio